Pallavi Kulkarni

ORCID: 0000-0002-8852-2334
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Parathyroid Disorders and Treatments
  • Vitamin D Research Studies
  • Bone health and treatments
  • Myasthenia Gravis and Thymoma
  • Nonmelanoma Skin Cancer Studies
  • Pituitary Gland Disorders and Treatments
  • CAR-T cell therapy research
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • Histone Deacetylase Inhibitors Research
  • Intraoperative Neuromonitoring and Anesthetic Effects
  • Cutaneous lymphoproliferative disorders research

All India Institute of Medical Sciences Bhopal
2025

Penn State Milton S. Hershey Medical Center
2023-2024

Hershey (United States)
2023

Oklahoma State Department of Health
2023

Pennsylvania State University
2023

<title>Abstract</title> KDM5B, a lysine-specific histone demethylase, is widely upregulated in breast cancer. The current study investigated the role of KDM5B cancer and explored repurposing potential antiviral drug abacavir (ABC). cytotoxic effects effect ABC sensitization on doxorubicin (DOX) efficacy were evaluated using 2-D 3-D cell culture models. expression was elevated tissues compared to normal tissues. <italic>In vitro</italic> studies demonstrated that treatment reduced cells...

10.21203/rs.3.rs-6208718/v1 preprint EN Research Square (Research Square) 2025-04-03

Introduction Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer in White population. Unfortunately, prognosis of advanced cSCC poor, and management can be challenging. Until recently, choice systemic medications was limited, those that were available had modest efficacy. Cemiplimab an anti–programmed cell-death protein 1 inhibitor first immunotherapeutic agent approved for treatment metastatic or locally cSCC. The purpose this study to evaluate efficacy cemiplimab...

10.1097/sap.0000000000003847 article EN Annals of Plastic Surgery 2024-04-01

Introduction: Pituitary adenomas are rare in the pediatric population. In patients under 18 years of age, many pituitary benign and managed with surgical resection, yet standardized guidelines do not exist for postoperative management. This study aimed to identify current medication practices surrounding endoscopic, endonasal transsphenoidal surgery, including prescription patterns hormone therapy, antibiotics, narcotics.

10.1055/s-0043-1762099 article EN Journal of Neurological Surgery Part B Skull Base 2023-02-01
Coming Soon ...